This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AI is rapidly transforming the way health systems deliver care by streamlining workflows, driving efficiency and improving patient outcomes. But who should be leading this revolution? According to Jonathan Joshi, MD, Professor of Radiology at UofL Health and AI champion, the answer is clear: radiologists. “I think radiologists should be the ones driving AI in the healthcare system, and I do think that they need to have a seat at the table, Joshi said.
The Radiation Oncology Case Rate Program (ROCR) Act continues to face an uphill battle on the legislative stage, but proponents say they have momentum on their side. The ROCR Act, which aims to shift radiation reimbursement from fee-for-service to bundled payments, was reintroduced in Congress on March 14. Were enthusiastic about it, said Chris Corso, MD, PhD, government relations committee vice chair at the American Society for Radiation Oncology (ASTRO).
This is a brief adjunct to my post on using Autohotkey in Radiology (which basically every radiologist should be doing, by the way). I include it here not because I expect many people to run into the same problem I did but rather because it’s a good example of the not-so-challenging troubleshooting that we shouldn’t be scared to do in our quest for a better workflow.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The American Association of Physicists in Medicine recently convened a panel of industry experts, devising a list of issues with the new quality metric.
PET/CT scans with an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients, researchers have reported. A team led by radiologists in Nairobi, Kenya, found metastases in supraclavicular (SC) lymph nodes in 8% of a large group of patients, and the group suggested adding consideration of the site during the initial diagnostic workup of patients.
PET/CT scans with an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients, researchers have reported. A team led by radiologists in Nairobi, Kenya, found metastases in supraclavicular (SC) lymph nodes in 8% of a large group of patients, and the group suggested adding consideration of the site during the initial diagnostic workup of patients.
My first Backtable episode about the rad shortage, the job market, and PE in radiology was back in 2023. I’m back on Backtable this week with a wide-ranging conversation about the job market, teleradiology, updates in the world of radiology private equity, etc etc. Always fun to chat with Ally and Mike, they’re awesome. Though, for the record, I do not condone and categorically reject any label that contains or alludes to the phrase “thought leader.” // During the show, A
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Medical image experts demonstrated superior perceptual accuracy in response to visual illusions compared with a control group, according to recent research. The finding offers new evidence of how expertise and training may impact mechanisms underpinning visual perception, noted lead author Radoslaw Wincza, PhD, a behavioral scientist at Lancaster University in the U.K., and colleagues.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The 2025 Medicare reimbursement updates bring significant changes for healthcare providers, particularly in coronary computed tomography angiography (CCTA) and other imaging services. While CCTA reimbursement rates have increased, the overall Medicare Physician Fee Schedule (MPFS) faces a 2.83% reduction in the conversion factor, impacting reimbursement for many radiology procedures ( CMS, 2025 MPFS Final Rule ).
Medusa has reportedly targeted over 300 victims including SimonMed Imaging, hospitals, law firms and manufacturers, according to the cybersecurity advisory.
The U.S. Food and Drug Administration (FDA) announced that Medtronic has recalled its Pipeline Vantage 027 embolization device used to treat brain aneurysms, with 13 injuries and four deaths reported related to it. The recall is due to reports of a higher incidence of the flexible, braided tube part of the device failing to properly attach or stay attached to blood vessel walls during and after procedures, according to a March 18 recall notice.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
The U.S. spends more than twice as much on healthcare as other wealthy countries, yet faces worse outcomes, according to a recent report. As the reports title, Mirror, Mirror 2024: A Portrait of the Failing U.S. Health System, suggests, the U.S. health system is failing when using five measures access to care, care process, administrative efficiency, equity and health outcomes to compare it against nine other developed nations.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
Adherence to lung cancer screening (LCS) with low-dose CT (LDCT) decreases after baseline imaging, according to a study published March 18 in JAMA Network Open. The findings indicate that there's more work to be done to boost patient compliance with LCS, suggested a team led by Roger Kim, MD, of the University of Pennsylvania in Philadelphia. "In [our] study of adults undergoing LCS, screening adherence was associated with increased overall and early-stage lung cancer detection rates [but] adhe
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
PET/CT imaging with a new fibroblast activation protein inhibitor (FAPI) imaging agent detects more bone metastases than FDG-PET/CT in patients with different types of cancer, researchers have reported. In a retrospective analysis that included 293 patients, gallium-68 (Ga-68) DOTA-FAPI-04 uptake was greater than F-18 FDG uptake by both benign bone lesions and metastases, especially for osteoblastic metastasis, noted lead author Rui Guo, MD, of Peking University Cancer Hospital and Institute in
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Weight bearing CT offers a new way to evaluate knee instability and ACL injuries.- a fast, low-radiation, and highly detailed 3D imaging alternative to traditional methods. In a recent talk at AAOS 2025, Dr. Camillo Helito, MD, PhD, Prof highlighted groundbreaking research on using this technology to assess tibial translation, femoral tibial rotation, and post-operative knee laxity.
Researchers in Toronto used MRI scans to measure the brain as it heals after injury, only to find damage persists for a year after athletes are medically cleared to return to the field.
"Weve got a pipeline. and were hopeful we can execute and expand the footprint geographically," the company's CFO tells Oppenheimer Conference attendees.
In a large-scale prospective trial conducted at a breast screening program in Europe, fewer women were recalled based on AI analysis of their digital mammogram than those recalled due to consensus findings from radiologists. As a result, women with mammograms flagged by AI computer-aided detection (CAD) software may be under-recalled, potentially leading to a lower breast cancer detection rate, according to a team led by Karin Dembrower, MD, PhD, of Karolinska Institute in Sweden.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content